longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesLongbridge ProFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

XTL BioPharma

XTLB

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
  • XTL Biopharmaceuticals Nominates Gilai Dolev as External Director

    PUBT·Oct 14, 2026 at 08:07 PM
    XTLB0.00%
  • Weekly Recap | XTL BioPharma +2.43%, ahead of the S&P 500

    Weekly Review·Sep 5, 2026 at 08:26 AM
    XTLB0.00%
  • Fed Signals and Sector Shifts: The Balancing Act in Financial Holdings

    Global Report·Sep 4, 2026 at 10:13 AM
    UNM-0.28%XTLB0.00%
  • XTL Biopharma faces shareholder bid for derivative suit seeking NIS 100 million damages

    PUBT·Aug 5, 2026 at 09:42 PM
    XTLB0.00%
  • XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition

    Tip Ranks·Aug 5, 2026 at 09:11 PM
    XTLB0.00%
  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

    benzinga_article·Jul 14, 2026 at 12:05 PM
    BJDX-1.95%PLRZ-0.50%
  • 12 Health Care Stocks Moving In Monday's After-Market Session

    benzinga_article·Jun 15, 2026 at 09:05 PM
    PRFX+1.10%HITI-0.39%
  • XTL Announces Receipt of Staff Delist Determination from Nasdaq | XTLB Stock News

    StockTitan·May 22, 2026 at 12:10 PM
    XTLB0.00%
  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

    benzinga_article·Apr 29, 2026 at 05:05 PM
    SGMO0.00%DSGN+2.49%
  • XTL Biopharmaceuticals Surges 73% on Acquisition News

    Movers Alert·Apr 29, 2026 at 04:41 PM
    XTLB0.00%
  • XTL Biopharma (XTLB.US) Soars 63% After Psyga Bio Deal

    Movers Alert·Apr 29, 2026 at 03:01 PM
    XTLB0.00%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy